COVID19
Impact Summit 

#COVIS2020

Sessions

PhilB&WSquare (2)__1585918731_111.119.20

Phillippe Boremans

Crisis & Risk Communication Consultant

 What Corporate Communicators can learn from Emergency Risk Communicators.

  • The difference between Corporate Crisis and Emergency Risk Communications.

  • Experiences from the field - Epidemic/Pandemic Risk Communication in practice.

  • The synergies between Corporate Crisis and Emergency Risk Communications.

  • During & Post COVID19 Risk Communication - What's next?

0.jfif

Dr. Sylvie Bleker - van Eyk

Senior Director, PwC Cyber, Forensic & Privacy 
Professor, VU University

 

  • Examples of crises (COVID-19, investigations by authorities

  • Crises you could have prevented (preventive fraud measures)

  • Leadership in crisis

  • How best to act

  • Communication 

  • Never waste a good crisis

  • The aftermath of a crisis: emerge stronger 

COVID19 Impact - Crisis Management
 

Diego.jpg

Diego Iribarren

Director
EY

Long - Term Perspectives and
Emerging risks profile

  • We are not out of the woods of this crisis yet, a lot remains to be known yet

  • Opportunities for conversations for important change will emerge. It does not guarantee change, however

  • Real estate will restructure itself regardless. The office market will lose its historical attractiveness 

  • AI and the IoT will receive an important boost

  • In the short term, the extent of the economic damage will depend on how well governments are able to manage the health crisis, particularly coming out from the lockdown. 

1_edited.jpg

Dr. Absihek Saurav

Economist - Private Sector Development and Investment, The World Bank Group

The Impact of COVID-19 on Foreign Investor Confidence

  • Investor Confidence

  • Cascading effects of demand-cum-supply shocks operating on international businesses

  • Estimates of adverse effects – supply chains, output, employment, business performance.

  • Areas of government support

  • Conclusions.

asd.jfif

Zsofia Agnes Nagy

Supply Chain & Operations Expert,
Ex- Novo Nordisk

Prioritising or Sequencing of Strategic v/s Operational Activities During the Crisis in Supply Chain

  • Short overview of our company setup to enable understanding of the context

  • 3 key pillars we distinguish (strategic, standard operational & crisis operational or BCP activities)

  • Prioritising or sequencing or both? Why and how? - The decision making process

  • Resources and unique solutions

  • Lessons to learn from the hiccups surfacing and how to funnel them into the key focus areas for improvement

Chris.jpg

Chris Hardesty

Director, Healthcare & Life Sciences
KPMG

Repurposing Public- Private Partnerships

  •  Public-private partnerships for healthcare – the legacy trends

  •  what’s needed most now for the pandemic 

  • What the future of such collaborations is going to look like

Mirko Senatore.jpg

Mirko Senatore

Global Supply Chain Lead - European Distributor Markets, Pfizer

Managing the crisis: thoughts from a Pharma Supply Chain practitioner

  • Supply Chain Challenges in Pharma confronting the pandemic

  • The problem of stockpiling

  • Leadership at the time of COVID19

  • Learning from the crisis and future-proofing

Pankaj's Picture.jpg

Pankaj Krishna

Founder & CEO – Chrome Data Analytics & Media

  • Cascading effects of COVID19

  • Uncertainties of the pandemic

  • Long term impacts

0.jpg

Bhavik Doshi

Senior Product Development Specialist - Market Intelligence (Healthcare)
The Economist Intelligence Unit 

Impact of COVID 19 on chronic therapy management & healthcare value chain

  • Introduction to Digital Therapeutics

  • Current market landscape of Digital Therapeutics

  • FDA's guidance on Software as a Medical Device

  • How digital therapeutics will improve overall clinical outcomes by disrupting the value chain?

  • Improving compliance and adherence with digital therapeutics

(Audio Embedded)

More sessions and details will be updated shortly